oa Methemoglobinemia induced by Dapsone: A case report

References

1. Prasad R, Verma SK, Singh R, Hosmane G. Concomittant pulmonary tuberculosis and borderline leprosy with type-II lepra reaction in single patient. Lung India: Official Organ of Indian Chest Society. 2010; 27:(1):19.
   [Google Scholar]
2. Wolf R, Matz H, Orion E, Tuzun B, Tuzun Y. Dapsone. Dermatology online journal. 2002; 8:(1):.
   [Google Scholar]
3. Provost TT. Lupus band test. International journal of dermatology. 1981; 20:(7):475–81.
   [Google Scholar]
4. Guragain S, Upadhayay N, Bhattarai BM. Adverse reactions in leprosy patients who underwent dapsone multidrug therapy: a retrospective study. Clinical pharmacology: advances and applications. 2017;:9:73.
   [Google Scholar]
5. Bhat RM, Radhakrishnan K. A case report of fatal dapsone-induced agranulocytosis in an Indian midborderline leprosy patient. Leprosy review. 2003; 74:(2):167–70.
   [Google Scholar]
6. Srour M, Go A, Osmon S. A case of dapsone-induced methemoglobinemia. Chest. 2019; 156:(4):A2115.
   [Google Scholar]
7. Deps PD, Nasser S, Guerra P, Simon M, Birshner RDC, Rodrigues LC. Adverse effects from multi-drug therapy in leprosy: a Brazilian study. Leprosy review. 2007; 78:(3):216–22.
   [Google Scholar]
8. Esbenshade AJ, Ho RH, Shintani A, Zhao Z, Smith LA, Friedman DL. Dapsone-induced methemoglobinemia: A dose-related occurrence? Cancer. 2011; 117:(15):3485–92.
   [Google Scholar]
9. Swartzentruber GS, Yanta JH, Pizon AF. Methemoglobinemia as a complication of topical dapsone. N Engl J Med. 2015; 372:(5):491–2.
   [Google Scholar]
10. Kane GC, Hoehn SM, Behrenbeck TR, Mulvagh SL. Benzocaine-induced methemoglobinemia based on the Mayo Clinic experience from 28 478 transesophageal echocardiograms: incidence, outcomes, and predisposing factors. Archives of internal medicine. 2007; 167:(18):1977–82.
    [Google Scholar]
11. Ash-Bernal R, Wise R, Wright SM. Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals. Medicine. 2004; 83:(5):265–73.
    [Google Scholar]
12. Mack E. Co-oximetry. Pediatrics in review. 2007; 28:(2):73–4.
    [Google Scholar]
13. Haymond S, Cariappa R, Eby CS, Scott MG. Laboratory assessment of oxygenation in methemoglobinemia. Clinical Chemistry. 2005; 51:(2):434–44.
    [Google Scholar]
14. Barker SJ, Tremper KK, Hyatt J. Effects of methemoglobinemia on pulse oximetry and mixed venous oximetry. Anesthesiology. 1989; 70:(1):112–7.
    [Google Scholar]
15. Kelner M, Bailey D. Mismeasurement of methemoglobin (“methemoglobin revisited”). Clinical chemistry. 1985; 31:(1):168–9.
    [Google Scholar]
16. Woodhouse K, Henderson D, Charlton B, Peaston R, Rawlins M. Acute dapsone poisoning: clinical features and pharmacokinetic studies. Human toxicology. 1983; 2:(3):507–10.
    [Google Scholar]
17. Cortazzo JA, Lichtman AD. Methemoglobinemia: a review and recommendations for management. Journal of cardiothoracic and vascular anesthesia. 2014; 28:(4):1043–7.
    [Google Scholar]
18. Coleman MD, Coleman NA. Drug-induced methaemoglobinaemia. Drug safety. 1996; 14:(6):394–405.
    [Google Scholar]
19. Naymagon L, Berwick S, Kessler A, Lancman G, Gidwani U, Troy K. The emergence of methemoglobinemia amidst the COVID-19 pandemic. American journal of hematology. 2020.
    [Google Scholar]
20. Faley B, Chase H. A case of severe amyl nitrite induced methemoglobinemia managed with methylene blue. J clinic toxicol. 2012; 2:(4):127–8.
    [Google Scholar]
21. Tejesh C, Shivanna S, Manjunath A, Prathima P. ICU management of methemoglobinemia due to unknown compound poisoning. Journal of anaesthesiology, clinical pharmacology. 2013; 29:(1):139.
    [Google Scholar]